EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Identification of MTFR1 as a Novel Prognostic Biomarker and Putative Oncogene for Breast Cancer: A Multi‐Omics Analysis and in Vitro Experimental Validation

Ya Liu, Xiaofan Yuan, Hong Chen iD

IET Systems Biology · 2026-01 · 20 (1)

DOI: 10.1049/syb2.70080 ↗

Kurz gefasst

Fachartikel in der Zeitschrift IET Systems Biology, online erschienen am 01.07.2026. Verfasst von Ya Liu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Medicine, North Sichuan Medical College, Nanchong, Sichuan, China. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Breast Neoplasms, Mitochondrial Proteins, Oncogenes. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitochondrial Fission Regulator 1 ( MTFR1 ) plays a critical regulatory role in various malignancies; however, its specific function and clinical significance in breast cancer (BRCA) remain unexplored. This study systematically characterised MTFR1 by integrating multi‐omics data, spatial transcriptomics, and single‐cell sequencing, followed by in vitro experimental validation. MTFR1 was significantly overexpressed in BRCA tissues and predominantly localised to malignant cells. Functionally, MTFR1 was closely associated with cell cycle progression; in vitro knockdown significantly suppressed cell proliferation and induced cell cycle arrest. Clinically, high MTFR1 expression served as an independent predictor of poor prognosis and was linked to chemotherapy resistance. Cross‐cancer immunotherapy analyses revealed that MTFR1 exhibited improved predictive performance for anti‐PD‐1 response during the on‐treatment phase compared with pretreatment settings. This study elucidates the multidimensional role of MTFR1 as a putative oncogene in BRCA, highlighting it as a promising prognostic biomarker and therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biomarkers, TumorBreast NeoplasmsMitochondrial ProteinsOncogenesHumansFemalePrognosisCell Line, TumorMultiomicsGene Expression Regulation, NeoplasticCell Proliferation

Stichwörter der Autor:innen

bioinformaticscancergynaecology

Substanzen

Biomarkers, TumorMitochondrial Proteins

Autor:innen und Institutionen

  • Department of Clinical Medicine, North Sichuan Medical College, Nanchong, Sichuan, China.
  • Department of General Practice, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.

ORCID-Profile: Hong Chen

Zitieren

APA

Liu, Y., Yuan, X., & Chen, H. (2026). Identification of MTFR1 as a Novel Prognostic Biomarker and Putative Oncogene for Breast Cancer: A Multi‐Omics Analysis and in Vitro Experimental Validation. IET Systems Biology, 20(1). https://doi.org/10.1049/syb2.70080

Vancouver

Liu Y, Yuan X, Chen H. Identification of MTFR1 as a Novel Prognostic Biomarker and Putative Oncogene for Breast Cancer: A Multi‐Omics Analysis and in Vitro Experimental Validation. IET Systems Biology. 2026;20(1). doi:10.1049/syb2.70080

BibTeX
@article{Liu2026,
  author = {Liu, Ya and Yuan, Xiaofan and Chen, Hong},
  title = {Identification of MTFR1 as a Novel Prognostic Biomarker and Putative Oncogene for Breast Cancer: A Multi‐Omics Analysis and in Vitro Experimental Validation},
  journal = {IET Systems Biology},
  year = {2026},
  volume = {20},
  number = {1},
  doi = {10.1049/syb2.70080}
}
Kostenlos starten →